Synuclein-related assays (Oligo-SNCA, SNCA, pSNCA-129) appear to capture synuclein pathology related to PD, whereas NEFL seems to be a better marker for FTD, and p-tau217 for AD. The gene discussed is SNCA; the disease is frontotemporal dementia.